Since 2013, diagnoses of multiple sclerosis (MS) in Finland take less time after symptom onset and treatments follow the ...
Tiziana and Renaissance will partner to accelerate clinical development and potential commercial launch of nasal foralumab.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback